Visibly frail and malnourished children and women lay on rows of hospital beds, their bodies bearing the scars of six months of captivity deep in the Nigerian bush. The patients were among 163 ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A simple tweak could make Alzheimer’s blood tests far more reliable, ...

Altimmune (NASDAQ:ALT) said it has initiated patient enrollment in its global Phase III PERFORMA trial of pemvidutide for ...

Makes it easier for patients to proactively manage their care, engage with their doctors, and stay on track with treatment plans ...

Propel Bio Partners LP ("Propel"), an equity investment firm, today announced the continued progress of EIT Pharma, Inc. ("EIT Pharma" or the "Company"), a biotechnology company focused on developing ...

Protagonist Therapeutics remains a 'Strong Buy' driven by FDA approval of ICOTYDE for moderate-to-severe plaque psoriasis and strong partnership economics. Learn more about PTGX stock here.

Sen. Ron Wyden's Reimagining Healthcare events hear Oregonians' struggles as patients, physicians and advocates navigating ...

Team members provide health care services for patients in an area extending from Devils Lake to Thief River Falls, Minnesota.

For decades, millions of women have been told to lose weight, exercise more or simply “wait and see.” Many left doctors’ appointments feeling unheard, frustrated and still ...

Experts in Prader-Willi Syndrome on Tuesday raised safety concerns over Neurocrine's drug Vykat XR, ​citing serious adverse events reported in patients with the rare genetic disorder.

For many people living with peripheral artery disease (PAD), a common condition affecting the blood vessels, even a short walk can be painful, according to a news release. UnityPoint Health – ...

Norah O'Donnell sat down with her own doctor, Rachel Rubin, to tackle the important topic of menopause: How your body changes, why women may be needlessly suffering, and what you can actually do about ...